The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merus Labs International Inc

TSX: MSL
Delayed quote

$1.65

Today's change+0.01 +0.61%
Updated July 20 11:41 AM EDT. Delayed by at least 15 minutes.
 

Merus Labs International Inc

TSX: MSL
Delayed quote

$1.65

Today's change+0.01 +0.61%
Updated July 20 11:41 AM EDT. Delayed by at least 15 minutes.

Merus Labs International Inc Hits New 100-day High

Merus Labs International Inc is up today by $0.01 or 0.61% to $1.65 and setting a new 100-day high. Over the last five days, shares have gained 0.61% and 42.24% year to date. Shares have underperformed the S&P TSX by 5.64% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.11
Updated July 20 11:41 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-12.10%

Merus Labs International Inc has a net profit margin of -12.10%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.14%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue23263026
Total other revenue--------
Total revenue23263026
Gross profit14181917
Total cost of revenue88119
Total operating expense21302728
Selling / general / administrative5985
Research & development--------
Depreciation / amortization891010
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income1-43-2
Interest income (expense), net non-operating-2-2-3-2
Gain (loss) on sale of assets--------
Other--------
Income before tax-1-60-5
Income after tax-1-60-5
Income tax, total0000
Net income-1-60-5
Total adjustments to net income--------
Net income before extra. items-1-60-5
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-60-5
Inc. avail. to common incl. extra. items-1-60-5
Diluted net income-1-60-5
Dilution adjustment--------
Diluted weighted average shares117117117117
Diluted EPS excluding extraordinary itemsvalue per share-0.01-0.050.00-0.04
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.01-0.050.00-0.04